Role of plasmacytoid dendritic cells in lung-associated inflammation

Recent Patents on Inflammation and Allergy Drug Discovery

Volumn 4, Issue 2, 2010, Pages 138-143

  Sorrentino, Rosalinda ^a   Morello, Silvana ^a   Pinto, Aldo ^a  

^a UNIVERSITY OF SALERNO   (Italy)

Author keywords

Asthma; Chronic obstructive pulmonary disease (COPD); Dendritic Cells (DCs); Lung cancer; Lung infections; Myeloid DCs (mDCs); Plasmacytoid DCs (pDCs)

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CPG OLIGODEOXYNUCLEOTIDE; FLT3 LIGAND; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; INTERFERON; INTERLEUKIN 8; TOLL LIKE RECEPTOR 9;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ARTICLE; ASTHMA; AUTOIMMUNITY; CELL PROLIFERATION; CELL SURVIVAL; CELLULAR IMMUNITY; CHLAMYDOPHILA PNEUMONIAE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; EOSINOPHILIC AIRWAY INFLAMMATION; GENE EXPRESSION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INNATE IMMUNITY; LUNG CARCINOMA; LUNG INFECTION; NONHUMAN; PATHOGENESIS; PHENOTYPE; PLASMACYTOID DENDRITIC CELL; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT DISEASE; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; DENDRITIC CELLS; HUMANS; INTERFERON TYPE I; PATENTS AS TOPIC; PNEUMONIA; T-LYMPHOCYTES, REGULATORY; TH1 CELLS;

EID: 77954063759     PISSN: 1872213X     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221310791163062     Document Type: Article

References (60)

1. GeurtsvanKessel CH, Lambrecht BN. Division of labor between dendritic cell subsets of the lung. Mucosal Immonol 2008; 1: 442-50.
2. Henri S, Vremec D, Kamath A, Waithman J, Williams S, Benoist C, et al. The dendritic cell populations of mouse lymph nodes. J Immunol 2001; 167: 741-8.
3. Colonna M, Trichieri G, Liu YJ. Plasmacytoid dendritic cells in immunity. Nat Immunol 2004; 5(12): 1219-26.
4. Watarai, H., Sekine, E., Taniguchi, M. Membrane molecule expressed specifically in activated plasmacytoid dendritic cell. US20090162869 (2009).
5. Asselin-Paturel C, Brizard G, Pin JJ, Brière F, Trinchieri G. Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J Immunol 2003; 171(12): 6466-77.
6. Blasius AL, Giurisato E, Cella M, Schreiber RD, Shaw AS, Colonna M. Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation. J Immunol 2006; 177(5): 3260-5.
7. Krug A, French AR, Barchet W, Fischer JA, Dzionek A, Pingel JT, et al. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 2004; 21(1): 107-19.
8. Blom, B., Liu, Y.-J. Dendritic cells; methods. US6660523 (2003).
9. Hochrein, H., O'Keeffe, M. Induction of dendritic cell development with macrophage-colony stimulating factor (M-CSF) receptor ligands. US20090148405 (2009).
10. Belardelli, F., Ferrantini, M., Lapenta, C., Lattanzi, L., Parlato, S. Santini dendritic cells, uses therefor, and vaccines and methods comprising the same. US20090041792 (2009).
11. Yoneyama H, Matsuno K, Zhang Y, Nishiwaki T, Kitabatake M, Ueha S, et al. Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules. Int Immunol 2004; 16(7): 915-28.
12. Penna G, Sozzani S, Adorini L. Cutting edge: Selective usage of chemokine receptors by plasmacytoid dendritic cells. J Immunol 2001; 167; 1826-66.
13. Vanbervliet B, Bendriss-Vermare N, Massacrier C, Homey B, de Bouteiller O, Brière F, et al. The inducible CXCR3 ligands control plasmacytoid dendritic cell responsiveness to the constitutive chemokine stromal cell-derived factor 1 (SDF-1)/CXCL12. J Exp Med 2003; 198(5): 823-30.
14. Xu H, Zhang GX, Ciric B, Rostami A. IDO: A double-edged sword for T(H)1/T(H)2 regulation. Immunol Lett 2008; 121(1): 1-6.
15. Liu YJ. IPC: Professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 2005; 23: 275-306.
16. Hartmann, G., Bratzler, R.L., Krieg, A.M. Methods related to immunostimulatory nucleic acid-induced interferon. US20060286070 (2006).
17. Lipford, G.B., Forsbach, A., Uhlmann, E., Wagner, H. Abasic oligonucleotide as carrier platform for antigen and immunostimulatory agonist and antagonist. US20080113929 (2008).
18. Blasius AL, Colonna M. Sampling and signaling in plasmacytoid dendritic cells: The potential roles of Siglec-H. Trends Immunol 2006; 27(6): 255-60.
19. Kassner N, Krueger M, Yagita H, Dzionek A, Hutloff A, Kroczek R, et al. Cutting edge: Plasmacytoid dendritic cells induce IL-10 production in T cells via the Delta-like-4/Notch axis. J Immunol 2010; 184(2): 550-4.
20. Boonstra A, Rajsbaum R, Holman M, Marques R, Asselin-Paturel C, Pereira JP, et al. Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88-and TRIF-dependent TLR signals, and TLR-independent signals. J Immunol 2006; 177(11): 7551-8.
21. Cella M, Facchetti F, Lanzavecchia A, Colonna M. Plasmacytoid Dednritic cells activated by influenza virus and CD40L drive a potent TH1 polarization. Nat Immunol 2000; 1: 305-10.
22. Munn DH, Sharma MD, Baban B, Harding HP, Zhang Y, Ron D, et al. GCN2 kinase inTcells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. Immunity 2005; 22: 633-42.
23. Sharma MD, Baban B, Chandler P, Hou DY, Singh N, Yagita H, et al. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3- dioxygenase. J Clin Invest 2007; 117(9): 2570-82.
24. Prendergast GC. Immune escape as a fundamental trait of cancer: Focus on IDO. Oncogene 2008; 27(28): 3889-900.
25. Uyttenhove C, Pilotte L, Théate I, Stroobant V, Colau D, Parmentier N, et al. Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3- dioxygenase. Nat Med 2003; 9(10): 1269-74.
26. Katz JB, Muller AJ, Prendergast GC. Indoleamine 2,3-dioxygenase in T-cell tolerance and tumoral immune escape. Immunol Rev 2008; 222: 206-21.
27. Sorrentino R, Gray P, Chen S, Shimada K, Crother TR, Arditi M. Plasmacytoid dendritic cells prevent cigarette smoke and Chlamydophila pneumoniae - induced Th2 inflammatory responses. Am J Respir Cell Mol Biol 2009; [ahead of print] doi: 10.1165/rcmb.2009-0224OC.
28. Fallarino F, Grohmann U, You S, McGrath BC, Cavener DR, Vacca C, et al. The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol 2006; 176(11): 6752-61.
29. Tokita D, Mazariegos GV, Zahorchak AF, Chien N, Abe M, Raimondi G, et al. High PD-L1/CD86 ratio on plasmacytoid dendritic cells correlates with elevated T-regulatory cells in liver transplant tolerance. Transplantation 2008; 85(3): 369-77.
30. Puccetti P, Fallarino F. Generation of T cell regulatory activity by plasmacytoid dendritic cells and tryptophan catabolism. Blood Cells Mol Dis 2008; 40(1): 101-5.
31. Fabricius D, Neubauer M, Mandel B, Schütz C, Viardot A, Vollmer A, et al. Prostaglandin E2 inhibits IFN-alpha secretion and Th1 costimulation by human plasmacytoid dendritic cells via Eprostanoid 2 and E-prostanoid 4 receptor engagement. J Immunol 2010; 184(2): 677-84.
32. Demedts IK, Brusselle GG, Vermaelen KY, Pauwels RA. Identification and characterization of human pulmonary dendritic cells. Am J Respir Cell Mol Biol 2005; 32: 177-84.
33. Masten BJ, Olson GK, Tarleton CA, Rund C, Schuyler M, Mehran R, et al. Characterization of myeloid and plasmacytoid dendritic cells in human lung. J Immunol 2006; 177: 7784-93.
34. Geurtsvan KCH, Willart MA, Bergen IM, van Rijt LS, Muskens F, Elewaut D, et al. Dendritic cells are crucial for maintenance of tertiary lymphoid structures in the lung of influenza virus-infected mice. J Exp Med 2009; 206(11): 2339-49.
35. Winter C, Taut K, Länger F, Mack M, Briles DE, Paton JC, et al. FMS-like tyrosine kinase 3 ligand aggravates the lung inflammatory response to Streptococcus pneumoniae infection in mice: Role of dendritic cells. J Immunol 2007; 179(5): 3099-108.
36. Karnak D, Beder S. Treatment of Chlamydia pneumoniae infection and chronic obstructive pulmonary disease. Expert Opin Pharmacother 2002; 3(10): 1461-70.
37. Schröder NW, Crother TR, Naiki Y, Chen S, Wong MH, Yilmaz A, et al. Innate immune responses during respiratory tract infection with a bacterial pathogen induce allergic airway sensitization J Allergy Clin Immunol 2008; 122(3): 595-602.
38. Smit JJ, Lindell DM, Boon L, Kool M, Lambrecht BN, Lukacs NW. The balance between plasmacytoid DC versus conventional DC determines pulmonary immunity to virus infections. PLoS One 2008; 3(3): e1720.
39. Chung KF, Adcock IM. Multifaceted mechanisms in COPD: Inflammation, immunity, and tissue repair and destruction. Eur Respir J 2008; 31(6): 1334-56.
40. Sorrentino R, de Souza PM, Sriskandan S, Duffin C, Paul-Clark MJ, Mitchell JA. Pattern recognition receptors and interleukin-8 mediate effects of Gram-positive and Gram-negative bacteria on lung epithelial cell function. Br J Pharmacol 2008; 154(4): 864-71.
41. Freeman CM, Martinez FJ, Han MK, Ames TM, Chensue SW, Todt JC, et al. Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 180(12): 1179-88.
42. Tsoumakidou M, Demedts IK, Brusselle GG, Jeffery PK. Dendritic cells in chronic obstructive pulmonary disease: New players in an old game. Am J Respir Crit Care Med 2008; 177(11): 1180-6.
43. Baraldo S, Lokar OK, Turato G, Zuin R, Saetta M. The role of lymphocytes in the pathogenesis of asthma and COPD. Curr Med Chem 2007; 14(21): 2250-6.
44. Roghanian A, Drost EM, MacNee W, Howie SE, Sallenave JM. Inflammatory lung secretions inhibit dendritic cell maturation and function via neutrophil elastase. Am J Respir Crit Care Med 2006; 174(11): 1189-98.
45. de Heer HJ, Hammad H, Soullié T, Hijdra D, Vos N, Willart MA, et al. Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen. J Exp Med 2004; 200(1): 89-98.
46. Sakaguchi S, Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T. Regulatory T cells: How do they suppress immune responses? Int Immunol 2009; 21(10): 1105-11.
47. Lambrecht BN, Hammad H. Biology of lung dendritic cells at the origin of asthma. Immunity 2009; 31: 412-24.
48. Lambrecht B, Hammad H. Biology of lung dendritic Cells at the origin of asthma. Immunity 2009; 31: 412-24.
49. Puccetti P, Grohmann U. IDO and regulatory T cells: A role for reverse signalling and non-canonical NF-kappaB activation. Nat Rev Immunol 2007; 7(10): 817-23.
50. Xu H, Oriss TB, Fei M, Henry AC, Melgert BN, Chen L, et al. Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation. Proc Natl Acad Sci USA 2008; 105(18): 6690-5.
51. Kline JN, Krieg AM. Toll-like receptor 9 activation with CpG oligodeoxynucleotides for asthma therapy. Drug News Perspect 2008; 21(8): 434-9.
52. Bratzler, R.L. Petersen, D.M., Fouron, Y. Immunostimulatory nucleic acids for the treatment of asthma and allergy. US7585847 (2009).
53. Kool M, van Nimwegen M, Willart MA, Muskens F, Boon L, Smit JJ, et al. An anti-inflammatory role for plasmacytoid dendritic cells in allergic airway inflammation. J Immunol 2009; 183(2): 1074-82.
54. Jahrsdorfer B, Weiner GJ. CpG oligodeoxynucleotides as immunotherapy in cancer. Cancer Ther 2008; 3(1): 27-32.
55. Igney FH, Krammer PH. Immune escape of tumors: Apoptosis resistance and tumor counterattack. J Leuk Biol 2002; 71(6): 7-20.
56. Rakoff-Nahoum S, Medzhitov R. Toll-like receptors and cancer. Nat Rev Cancer 2009; 9(1): 57-63.
57. Krieg AM. Development of TLR9 agonist for cancer therapy. J Clin Invest 2007; 117(5): 1184-94.
58. Hasumi, K. Dendritic cell tumor injection (DCTI) therapy. US20090074713 (2009).
59. Hiraide A, Hiroishi K, Eguchi J, Ishii S, Doi H, Imawari M. Dendritic cells stimulated with cytidine oligodeoxynucleotides and interferon-α-expressing tumor cells effectively reduce outgrowth of established tumors in vivo. Cancer Sci 2008; 99(8): 1663-9.
60. Mellor, A., Munn, D. Induction of indoleamine 2,3-dioxygenase in dendritic cells by TLR ligands and uses thereof. US20090297540 (2009).